​

BioAtla (BCAB) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

BCAB Stock Forecast

BioAtla (BCAB) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 1512.90% increase from the last price of $0.31.

- $1 $2 $3 $4 $5 High: $5 Avg: $5 Low: $5 Last Closed Price: $0.31

BCAB Stock Rating

BioAtla stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (66.67%), 3 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 3 6 0 Strong Sell Sell Hold Buy Strong Buy

BCAB Price Target Upside V Benchmarks

TypeNameUpside
StockBioAtla1512.90%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.31$0.31$0.31
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-1---1
Dec, 25-11--2
Nov, 25-12--3
Oct, 25-12--3
Sep, 25-12--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 23, 2024Reni BenjaminJMP Securities$5.00$2.28119.30%1512.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 13, 2026Rodman & RenshawBuyinitialise
May 23, 2024JMP SecuritiesOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.76$-2.70$-2.58$-1.44----
Avg Forecast$-2.76$-2.87$-2.76$-1.53$-1.41$-1.42$-1.45$-1.21
High Forecast$-2.76$-2.87$-2.73$-1.53$-1.41$-0.86$-1.43$-1.21
Low Forecast$-2.76$-2.87$-2.78$-1.53$-1.41$-1.86$-1.47$-1.21
Surprise %--5.92%-6.52%-5.88%----

Revenue Forecast

$0 $16M $32M $48M $64M $80M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$250.00K-------
Avg Forecast$1.22M$1.50M$15.00M$11.00M$2.87M$19.70M$9.20M$77.95M
High Forecast$1.22M$1.50M$15.00M$11.00M$2.87M$19.70M$9.20M$77.95M
Low Forecast$1.22M$1.50M$15.00M$11.00M$2.87M$19.70M$9.20M$77.95M
Surprise %-79.51%-------

Net Income Forecast

$-140M $-120M $-100M $-80M $-60M $-40M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-95.41M$-105.28M$-123.46M-----
Avg Forecast$-131.87M$-137.33M$-131.74M$-72.86M$-67.37M$-64.99M$-69.28M$-57.81M
High Forecast$-131.87M$-137.33M$-130.54M$-72.86M$-67.37M$-41.29M$-68.46M$-57.81M
Low Forecast$-131.87M$-137.33M$-132.95M$-72.86M$-67.37M$-88.69M$-70.09M$-57.81M
Surprise %-27.65%-23.34%-6.29%-----

BCAB Forecast FAQ

Is BioAtla stock a buy?

BioAtla stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BioAtla is a favorable investment for most analysts.

What is BioAtla's price target?

BioAtla's price target, set by 9 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 1512.90% change from the previous closing price of $0.31.

How does BioAtla stock forecast compare to its benchmarks?

BioAtla's stock forecast shows a 1512.90% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for BioAtla over the past three months?

  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is BioAtla’s EPS forecast?

BioAtla's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.41, marking a -2.08% decrease from the reported $-1.44 in 2024. Estimates for the following years are $-1.42 in 2026, $-1.45 in 2027, and $-1.21 in 2028.

What is BioAtla’s revenue forecast?

BioAtla's average annual revenue forecast for its fiscal year ending in December 2025 is $2.87M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $19.7M, followed by $9.2M for 2027, and $77.95M for 2028.

What is BioAtla’s net income forecast?

BioAtla's net income forecast for the fiscal year ending in December 2025 stands at $-67.366M, representing a 0% decrease from the reported $0 in 2024. Projections indicate $-64.99M in 2026, $-69.277M in 2027, and $-57.811M in 2028.